{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "50242-933",
      "generic_name": "atezolizumab and hyaluronidase-tqjs",
      "labeler_name": "Genentech, Inc.",
      "brand_name": "Tecentriq Hybreza",
      "active_ingredients": [
        {
          "name": "ATEZOLIZUMAB",
          "strength": "1875 mg/15mL"
        },
        {
          "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
          "strength": "30000 U/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "50242-933-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01)  / 15 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20240912",
          "sample": false
        },
        {
          "package_ndc": "50242-933-86",
          "description": "1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86)  / 15 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20240912",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "INJECTION",
      "spl_id": "391adb08-e25a-4e3f-a14c-f52e03b73fe8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20240912",
      "product_id": "50242-933_391adb08-e25a-4e3f-a14c-f52e03b73fe8",
      "application_number": "BLA761347",
      "brand_name_base": "Tecentriq Hybreza",
      "pharm_class": [
        "Antibodies [CS]",
        "Antibodies",
        "Monoclonal [CS]",
        "Antibodies",
        "Monoclonal",
        "Humanized [CS]",
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]",
        "Programmed Death Receptor-1 Blocking Antibody [EPC]",
        "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}